Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision bump from v3.6.5 to v3.6.6 for the page, signaling a minor maintenance/update to the site framework. This does not alter the study details, eligibility criteria, or other user-facing content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a minor update to the page's version. No substantive content changes are evident in the provided data.SummaryDifference0.1%

- Check40 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, reflecting a minor update to the page's version and metadata.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision tag 'Revision: v3.6.3' was added and the previous tag 'Revision: v3.6.2' was removed, indicating a small update to the page's revision history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2. This reflects a minor template/software update to the page rather than a change to the study details.SummaryDifference0.1%

- Check83 days agoChange DetectedNew navigation and guidance sections were added to the study details page (How to Read a Study Record, Common Questions, How to Join a Study), and a recruitment status indicator 'No longer looking for participants' was introduced. The label formatting for Intervention/Treatment was adjusted and the old heading 'Intervention / Treatment' as well as the older revision tag were removed.SummaryDifference0.4%

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.